Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Swift

Showing results (351-360 of 463) with videos related to

Pageof 47
Sort By:
Ear and Hearing|February 3, 2026
Wideband Absorbance Among Aboriginal and/or Torres Strait Islander and Non-Aboriginal Children With Suspected Otitis Media Living in an Australian Urban AreaTamara Veselinović, Wilhelmina H A M Mulders, Helen Goulios, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 28, 2022
A Simple and Reproducible In Vivo Rabbit Phonation Model for Glottic InsufficiencyWilliam M Swift, Ian T Churnin, Osama A Hamdi, et al.
Sleep|January 11, 2024
Altered sleep architecture following consecutive nights of presleep alcoholKatie S McCullar, David H Barker, John E McGeary, et al.
Nature Communications|May 15, 2024
Sustained bacterial N<sub>2</sub>O reduction at acidic pHGuang He, Gao Chen, Yongchao Xie, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 6, 2017
A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteersCarolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, et al.
Data in Brief|December 8, 2017
Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parametersCarolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 9, 2010
Increased training loads do not magnify cancellous bone gains with rodent jump resistance exerciseJ M Swift, H G Gasier, S N Swift, et al.
Cytokine|August 6, 1999
Glucagon decreases cytokine induction of nitric oxide synthase and action on insulin secretion in RIN5F cells and rat and human islets of LangerhansV D Belin, J G Mabley, R F James, et al.
Joint Commission Journal on Quality and Patient Safety|May 16, 2018
1,300 Days and Counting: A Risk Model Approach to Preventing Retained Foreign Objects (RFOs)Erika G Duggan, Jimmy Fernandez, Mary May Saulan, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 9, 2021
Bisphenol S and Bisphenol F Are Less Disruptive to Cardiac Electrophysiology, as Compared With Bisphenol ATomas M Prudencio, Luther M Swift, Devon Guerrelli, et al.
Pageof 47

Showing results (351-360 of 463) with videos related to

Sort By:
Pageof 47
Ear and Hearing|February 3, 2026
Wideband Absorbance Among Aboriginal and/or Torres Strait Islander and Non-Aboriginal Children With Suspected Otitis Media Living in an Australian Urban AreaTamara Veselinović, Wilhelmina H A M Mulders, Helen Goulios, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 28, 2022
A Simple and Reproducible In Vivo Rabbit Phonation Model for Glottic InsufficiencyWilliam M Swift, Ian T Churnin, Osama A Hamdi, et al.
Sleep|January 11, 2024
Altered sleep architecture following consecutive nights of presleep alcoholKatie S McCullar, David H Barker, John E McGeary, et al.
Nature Communications|May 15, 2024
Sustained bacterial N<sub>2</sub>O reduction at acidic pHGuang He, Gao Chen, Yongchao Xie, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|August 6, 2017
A Phase I randomized clinical trial testing the safety, tolerability and preliminary pharmacokinetics of the mGluR5 negative allosteric modulator GET 73 following single and repeated doses in healthy volunteersCarolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, et al.
Data in Brief|December 8, 2017
Dataset for Phase I randomized clinical trial for safety and tolerability of GET 73 in single and repeated ascending doses including preliminary pharmacokinetic parametersCarolina L Haass-Koffler, Kimberly Goodyear, Victoria M Long, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|October 9, 2010
Increased training loads do not magnify cancellous bone gains with rodent jump resistance exerciseJ M Swift, H G Gasier, S N Swift, et al.
Cytokine|August 6, 1999
Glucagon decreases cytokine induction of nitric oxide synthase and action on insulin secretion in RIN5F cells and rat and human islets of LangerhansV D Belin, J G Mabley, R F James, et al.
Joint Commission Journal on Quality and Patient Safety|May 16, 2018
1,300 Days and Counting: A Risk Model Approach to Preventing Retained Foreign Objects (RFOs)Erika G Duggan, Jimmy Fernandez, Mary May Saulan, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 9, 2021
Bisphenol S and Bisphenol F Are Less Disruptive to Cardiac Electrophysiology, as Compared With Bisphenol ATomas M Prudencio, Luther M Swift, Devon Guerrelli, et al.
Pageof 47